Ticker

NEW YORK, Aug. 31, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on September 30, 2026, has a record date of September 15, 2026, and has an ex-date of September 15, 2026.

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") announced today that its Board of Directors has approved a $25 million increase in the committed debt financing available under its revolving debt financing facility ("Revolving Loan Facility") with a major unaffiliated financial institution, as well as the issuance of $10 million in additional Mandatory…

NEW YORK, July 31, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on August 31, 2026, has a record date of August 17, 2026, and has an ex-date of August 17, 2026.

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS - Get Free Report) shares passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $6.79 and traded as low as $6.11. Neuberger Berman High Yield Strategies Fund shares last traded at $6.12, with a volume of 68,514 shares.

Ventripoint's VMS+ platform to be evaluated alongside a second AI technology in a landmark NHS study exploring earlier detection of chemotherapy-related heart damage   Toronto, Ontario – TheNewswire – July 20, 2026 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) a leader in the application of artificial intelligence to echocardiography, today announced that its VMS+ technology…